Clinical measures in chronic neuropathic pain are related to the Kennedy and endocannabinoid pathways.
Authors
Bourke SL, Gonzalez ES, Islam B, Stephenson J, Finn DP, McHugh PC
Abstract
Chronic neuropathic pain (CNP) is a debilitating condition, often refractory to currently available drugs. Understanding biochemical alterations in peripheral tissues such as blood will be useful for understanding underlying pathophysiological processes relating to CNP.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
